## Monitoring Disease Activity in Pemphigus Vulgaris ### Role of Serum Antibody Detection **Key Point:** Indirect immunofluorescence (IIF) or ELISA for circulating anti-desmoglein antibodies is the investigation of choice for monitoring disease activity, predicting flares, and guiding treatment intensity in patients with established pemphigus vulgaris. **High-Yield:** The serum anti-desmoglein antibody titer correlates with: - Disease activity (higher titer = more active disease) - Risk of clinical flare (rising titer predicts relapse) - Response to therapy (falling titer indicates treatment efficacy) - Prognosis (persistently high titers suggest need for aggressive therapy) ### Serological Classification of Pemphigus **Mnemonic:** **"Dsg3 + Dsg1 = Mucocutaneous; Dsg3 alone = Mucosal"** | Pemphigus Type | Anti-Dsg3 | Anti-Dsg1 | Clinical Pattern | |---|---|---|---| | **Pemphigus Vulgaris (Mucocutaneous)** | + | + | Oral + skin involvement | | **Pemphigus Vulgaris (Mucosal)** | + | − | Oral only (limited cutaneous) | | **Pemphigus Foliaceus** | − | + | Superficial skin only; no oral | | **Seronegative Pemphigus** | − | − | Rare; diagnosis by DIF + histology | **Clinical Pearl:** In this patient with established diagnosis, serum antibody titer serves as a non-invasive biomarker of disease burden. A rising titer during remission signals impending flare, allowing preemptive therapy escalation. ### Why Other Investigations Are Not Suitable for Monitoring **DIF (Option 0):** While DIF confirms diagnosis, repeating it does not quantify disease activity. The in-situ IgG deposition remains positive regardless of clinical improvement and does not guide therapy decisions. **Histopathology (Option 2):** Histological acantholysis persists even during clinical remission and does not correlate with disease activity or prognosis. It is not useful for monitoring. **Immunoelectron Microscopy (Option 3):** This is a research tool that visualizes ultrastructural immune deposition but is not clinically available, not practical for serial monitoring, and does not provide prognostic information beyond what DIF and serology offer. ### ELISA vs. IIF **High-Yield:** Modern practice increasingly uses ELISA for anti-desmoglein antibodies because: - Quantitative (provides numerical titer) - More sensitive and specific than IIF - Standardized across laboratories - Easier to trend over time - Correlates better with disease activity IIF is still acceptable but less precise for quantification. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.